The FIT40 Podcast #159: How To Get The Best Results On GLP-1 Agonists (Semaglutide, Ozempic, Tirzepatide, etc.) w/ Dr. Gabby Gerbino
4 snips
Jan 28, 2024 Dr. Gabby Gerbino, a medical expert in GLP-1 agonists, delves into the impact of medications like Semaglutide and Ozempic on obesity and diabetes management. She discusses the essential balance between medication and lifestyle changes while highlighting the risks of questionable sources for prescriptions. The conversation also uncovers the vital connection between nutrition and overall health, including hair vitality, and offers insight into effective workout strategies, emphasizing the importance of nourishment and exercise for optimal results.
AI Snips
Chapters
Transcript
Episode notes
GLP-1 Agonists Explained
- GLP-1 agonists like Ozempic and Wegovy mimic natural hormones to decrease appetite and slow digestion.
- These medications, combined with lifestyle changes, resulted in 15-20% weight loss in studies, comparable to bariatric surgery.
Managing GLP-1 Side Effects
- Start GLP-1 medications at low doses and increase gradually to manage side effects like nausea.
- Eat slower to adjust to the medication's effects on digestion and fullness.
Who Should Use GLP-1s?
- GLP-1 medications are intended for individuals with a BMI of 30 or greater, or those with a BMI of 27+ with comorbidities.
- These drugs are primarily for people struggling with significant weight, not vanity weight loss.